Literature DB >> 6600659

Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia.

R C Marshall, J H Tillisch, M E Phelps, S C Huang, R Carson, E Henze, H R Schelbert.   

Abstract

Studies have shown that the extraction of glucose per unit flow is increased in moderately ischemic myocardium primarily due to anaerobic glucose metabolism manifested as lactate production, whereas myocardial infarction is characterized by the loss of metabolically active myocardium. To determine the feasibility of demonstrating these metabolic abnormalities reflecting both ischemia and infarction, we used positron computed tomography (PCT) to evaluate relative regional myocardial exogenous glucose utilization and perfusion in 15 patients with recent myocardial infarction. The positron-emitting tracers of glucose metabolism and perfusion, 18F-2-fluoro-2-deoxyglucose (FDG) and N-13 ammonia, respectively, were used. Fourteen of 19 documented infarctions were demonstrated by PCT to have concordantly decreased glucose utilization and perfusion. However, in an additional 11 regions, glucose utilization was disproportionately increased relative to perfusion, consistent with ischemic glucose consumption. These findings correlated with the presence of postinfarction angina, the site of ischemic electrocardiographic changes during chest pain, and the presence of regional left ventricular dysfunction and severe coronary artery disease. Because three ECG infarct zones not detected by PCT demonstrated ischemic glucose utilization, only two of 19 electrocardiographically defined infarctions had no detectable metabolic abnormality. We conclude that the changes in regional FDG and N-13 ammonia concentrations detected with PCT in patients who had had a recent myocardial infarction are consistent with regional exogenous glucose utilization and perfusion in moderately ischemic and irreversibly infarcted myocardium. This approach has the potential to identify and differentiate resting myocardial ischemia from infarction and to assess tissue viability after an ischemic event.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600659     DOI: 10.1161/01.cir.67.4.766

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  81 in total

1.  BMIPP compared with PET metabolism.

Authors:  E Tadamura; N Tamaki; T Kudoh; N Hattori; J Konishi
Journal:  Int J Card Imaging       Date:  1999-02

Review 2.  Fluorine-18-deoxyglucose SPECT and coincidence imaging for myocardial viability: Clinical and technologic issues.

Authors:  V Dilsizian; S L Bacharach; M M Khin; M F Smith
Journal:  J Nucl Cardiol       Date:  2001 Jan-Feb       Impact factor: 5.952

3.  F-18 fluorodeoxyglucose imaging in myocardial ischemia: beyond myocardial viability.

Authors:  J A Arrighi
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

4.  Detection of scarred and viable myocardium using a new magnetic resonance imaging technique: blood oxygen level dependent (BOLD) MRI.

Authors:  M Egred; A Al-Mohammad; G D Waiter; T W Redpath; S K Semple; M Norton; A Welch; S Walton
Journal:  Heart       Date:  2003-07       Impact factor: 5.994

5.  Myocardial oxidative metabolism in normal subjects in fasting, glucose loading and dobutamine infusion states.

Authors:  N Tamaki; Y Magata; N Takahashi; M Kawamoto; T Torizuka; Y Yonekura; S Nishizawa; N Sadato; E Tadamura; S Ono
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

Review 6.  Hibernation and myocardial ischemia: clinical detection by positron emission tomography.

Authors:  N G Uren; P G Camici
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

Review 7.  Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part II).

Authors:  L L Ponto; J A Ponto
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

8.  Metabolic fate of extracted glucose in normal human myocardium.

Authors:  J A Wisneski; E W Gertz; R A Neese; L D Gruenke; D L Morris; J C Craig
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

9.  Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog.

Authors:  E J Barrett; R G Schwartz; C K Francis; B L Zaret
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

Review 10.  Magnetocardiography for the diagnosis of coronary artery disease: a systematic review and meta-analysis.

Authors:  Rajender Agarwal; Abhimanyu Saini; Tareq Alyousef; Craig A Umscheid
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-08-13       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.